Research location
Ouagadougou
Burkina Faso
Advertisement
Research activity in Ouagadougou
Burkina FasoCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Ouagadougou
10 linked trials · page 1 of 1Assessing the Effects of Cool Roofs on Indoor Environments and HealthNCT06579950 · 2024-09-04 · 1 site observation
RECRUITING
Improving Care and Community Representation for Adolescents and Young Adults Living With HIV in West AfricaNCT05405322 · 2021-04-07 · 2 site observations
UNKNOWN
Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)NCT03459157 · 2017-11-20 · 1 site observation
COMPLETED
Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & SafetyNCT03519503 · 2017-02-27 · 1 site observation
COMPLETED
A Survey of Hospitalizations in Cardiology Units in Sub-Saharan AfricaNCT03231449 · 2017-02-01 · 1 site observation
UNKNOWN
Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) AdultsNCT02564523 · 2015-11-06 · 1 site observation
COMPLETED
Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan AfricaNCT02626286 · 2015-06-01 · 1 site observation
COMPLETED
Third Line Antiretroviral Treatment Optimization in Sub-Saharan AfricaNCT02025868 · 2013-03-01 · 1 site observation
UNKNOWN
Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of AgeNCT01127204 · 2011-06-01 · 2 site observations
COMPLETED
Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by BreastfeedingNCT00640263 · 2009-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.